A Pilot Study of KPL-914 in Recurrent Pericarditis
Public ClinicalTrials.gov record NCT03980522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis
Study identification
- NCT ID
- NCT03980522
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
- Industry
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Interventions
- KPL-914 Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 23, 2018
- Primary completion
- May 16, 2019
- Completion
- May 16, 2019
- Last update posted
- May 26, 2021
2018 – 2019
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medstar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Avail Clinical Research, LLC | DeLand | Florida | 32720 | — |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | — |
| Affinity Clinical Research Institute | Oak Brook | Illinois | 60523 | — |
| Franciscan Physician Network Indiana Heart Physicians Cardiovascular Research Program | Indianapolis | Indiana | 46237 | — |
| Research Integrity, LLC | Owensboro | Kentucky | 42303 | — |
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55407 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Ellipsis Research Group | Brooklyn | New York | 11215 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| BI Research Center | Houston | Texas | 77084 | — |
| University of Vermont Medical Center | Burlington | Vermont | 05401 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03980522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03980522 live on ClinicalTrials.gov.